Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells

Abstract

Reovirus shows considerable potential as an oncolytic agent for Ras-activated tumors and is currently in clinical trials. Here we ask whether such tumor cell lines can acquire resistance to reoviral oncolysis. We challenged human HT1080 fibrosarcoma cells that carry a Ras mutation by prolonged exposure to reovirus, thereby yielding highly virus-resistant HTR1 cells. These cells are persistently infected with reovirus, exhibit high Ras activity and retain the original Ras gene mutation, showing that resistance to reovirus can be displayed in cells with active Ras. The HTR1 cells also exhibit reduced cellular cathepsin B activity, which normally contributes to viral entry and activation. Persistently infected HTR1 cells were not tumorigenic in vivo, whereas immunologically cured virus-free HTR1 cells were highly tumorigenic. Thus, acquisition of resistance to reovirus may constrain therapeutic strategies. To determine whether reoviral resistance is associated with a general reduction in apoptotic potential, we challenged the HTR1 cells with apoptotic inducers and E1B-defective adenovirus, resulting in significant apoptosis and cell death following both approaches. Therefore, even if resistance to reoviral oncolysis should arise in tumor cells in vivo, other therapeutic strategies may nevertheless remain effective.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Ahmed R, Canning WM, Kauffman RS, Sharpe AH, Hallum JV, Fields BN . (1981). Role of the host cell in persistent viral infection: coevolution of L cells and reovirus during persistent infection. Cell 25: 325–332.

    Article  CAS  Google Scholar 

  • Baer GS, Ebert DH, Chung CJ, Erickson AH, Dermody TS . (1999). Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J Virol 73: 9532–9543.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Barrett AJ, Kirschke H . (1981). Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 80: 535–561.

    Article  CAS  Google Scholar 

  • Brown R, Marshall CJ, Pennie SG, Hall A . (1984). Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. EMBO J 3: 1321–1326.

    Article  CAS  Google Scholar 

  • Buttle DJ, Murata M, Knight CG, Barrett AJ . (1992). CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch Biochem Biophys 299: 377–380.

    Article  CAS  Google Scholar 

  • Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL . (2001). Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene 20: 6910–6919.

    Article  CAS  Google Scholar 

  • Coffey MC, Strong JE, Forsyth PA, Lee PW . (1998). Reovirus therapy of tumors with activated Ras pathway. Science 282: 1332–1334.

    Article  CAS  Google Scholar 

  • Connolly JL, Dermody TS . (2002). Virion disassembly is required for apoptosis induced by reovirus. J Virol 76: 1632–1641.

    Article  CAS  Google Scholar 

  • Danis C, Mabrouk T, Faure M, Lemay G . (1997). Interferon has no protective effect during acute or persistent reovirus infection of mouse SC1 fibroblasts. Virus Res 51: 139–149.

    Article  CAS  Google Scholar 

  • De Rooij J, Bos JL . (1997). Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14: 623–625.

    Article  CAS  Google Scholar 

  • Dermody TS . (1998). Molecular mechanisms of persistent infection by reovirus. Curr Top Microbiol Immunol 233: 1–22.

    CAS  PubMed  Google Scholar 

  • Dermody TS, Chappell JD, Hofler JG, Kramp W, Tyler KL . (1995). Eradication of persistent reovirus infection from a B-cell hybridoma. Virology 212: 272–276.

    Article  CAS  Google Scholar 

  • Duncan MR, Stanish SM, Cox DC . (1978). Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol 28: 444–449.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Duursma AM, Agami R . (2003). Ras interference as cancer therapy. Semin Cancer Biol 13: 267–273.

    Article  CAS  Google Scholar 

  • Ebert DH, Kopecky-Bromberg SA, Dermody TS . (2004). Cathepsin B is inhibited in mutant cells selected during persistent reovirus infection. J Biol Chem 279: 3837–3851.

    Article  CAS  Google Scholar 

  • Hashiro G, Loh PC, Yau JT . (1977). The preferential cytotoxicity of reovirus for certain transformed cell lines. Arch Virol 54: 307–315.

    Article  CAS  Google Scholar 

  • Kominsky DJ, Bickel RJ, Tyler KL . (2002). Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ 9: 926–933.

    Article  CAS  Google Scholar 

  • Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL . (2006). Inhibition of PKR by RNA and DNA viruses. Virus Res 119: 100–110.

    Article  CAS  Google Scholar 

  • Loken SD, Norman K, Hirasawa K, Nodwell M, Lester WM, Demetrick DJ . (2004). Morbidity in immunosuppressed (SCID/NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic. Cancer Biol Ther 3: 734–738.

    Article  CAS  Google Scholar 

  • Meusel TR, Imani F . (2003). Viral induction of inflammatory cytokines in human epithelial cells follows a p38 mitogen-activated protein kinase-dependent but NF-kappa B-independent pathway. J Immunol 171: 3768–3774.

    Article  CAS  Google Scholar 

  • Mosmann T . (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63.

    Article  CAS  Google Scholar 

  • Nagata L, Masri SA, Mah DC, Lee PW . (1984). Molecular cloning and sequencing of the reovirus (serotype 3) S1 gene which encodes the viral cell attachment protein sigma 1. Nucleic Acids Res 12: 8699–8710.

    Article  CAS  Google Scholar 

  • Norman KL, Lee PW . (2005). Not all viruses are bad guys: the case for reovirus in cancer therapy. Drug Discov Today 10: 847–855.

    Article  CAS  Google Scholar 

  • Paterson H, Reeves B, Brown R, Hall A, Furth M, Bos J et al. (1987). Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 51: 803–812.

    Article  CAS  Google Scholar 

  • Samuel CE . (1998). Reoviruses and the interferon system. Curr Top Microbiol Immunol 233: 125–145.

    CAS  PubMed  Google Scholar 

  • Schotte P, Schauvliege R, Janssens S, Beyaert R . (2001). The cathepsin B inhibitor z-FA.fmk inhibits cytokine production in macrophages stimulated by lipopolysaccharide. J Biol Chem 276: 21153–21157.

    Article  CAS  Google Scholar 

  • Shiratsuchi A, Kaido M, Takizawa T, Nakanishi Y . (2000). Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages. J Virol 74: 9240–9244.

    Article  CAS  Google Scholar 

  • Smith RE, Zweerink HJ, Joklik WK . (1969). Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39: 791–810.

    Article  CAS  Google Scholar 

  • Steele TA, Cox DC . (1996). Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response. Proc Soc Exp Biol Med 212: 63–68.

    Article  CAS  Google Scholar 

  • Steele TA, Hauser CC . (2005). The role of interferon-alpha in a successful murine tumor therapy. Exp Biol Med (Maywood) 230: 487–493.

    Article  CAS  Google Scholar 

  • Stewart MJ, Smoak K, Blum MA, Sherry B . (2005). Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. J Virol 79: 2979–2987.

    Article  CAS  Google Scholar 

  • Stoeckel J, Hay JG . (2006). Drug evaluation: Reolysin – wild-type reovirus as a cancer therapeutic. Curr Opin Mol Ther 8: 249–260.

    CAS  PubMed  Google Scholar 

  • Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW . (1998). The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 17: 3351–3362.

    Article  CAS  Google Scholar 

  • Taber R, Alexander V, Whitford W . (1976). Persistent reovirus infection of CHO cells resulting in virus resistance. J Virol 17: 513–524.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Teodoro JG, Halliday T, Whalen SG, Takayesu D, Graham FL, Branton PE . (1994). Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activity. J Virol 68: 776–786.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tyler KL . (2001). Mammalian reoviruses. In: Knipe DM, Howley PM (eds). Lippincott Fields Virology. Williams & Wilkens: Philadelphia, pp 1729–1745.

    Google Scholar 

  • Wong H, Anderson WD, Cheng T, Riabowol KT . (1994). Monitoring mRNA expression by polymerase chain reaction: the ‘primer-dropping’ method. Anal Biochem 223: 251–258.

    Article  CAS  Google Scholar 

  • Yeung MC, Chang DL, Camantigue RE, Lau AS . (1999). Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc Natl Acad Sci USA 96: 11860–11865.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Portions of this work were completed as part of a PhD thesis by MK. This study was supported by research grants to RNJ from the Alberta Cancer Board and the Canadian Institutes for Health Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R N Johnston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, M., Egan, C., Alain, T. et al. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells. Oncogene 26, 4124–4134 (2007). https://doi.org/10.1038/sj.onc.1210189

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210189

Keywords

This article is cited by

Search

Quick links